DNA METHYLATION LEVEL OF SPECIFIC CPG SITES FOR PREDICTION OF GLYCEMIC RESPONSE AND TOLERANCE TO METFORMIN TREATMENT IN TYPE 2 DIABETIC PATIENTS

摘要

The present invention relates to methods and arrays for determining the methylation status of DNA. The present invention also relates to methods and arrays for determining if a type 2 diabetic individual is able to respond to and/or tolerate a particular treatment regime, e.g. metformin treatment.